It was shown in human and murine glioblastoma cells that by inhibition of GLUT/SLC2A with indinavir, ritonavir and by inhibition of the Na/glucose antiporter type 2 (SGLT2/SLC5A2) superfamily with phlorizin, glucose consumption and cell proliferation were decreased31. The gene discussed is SLC5A2; the disease is glioblastoma.